{"product_id":"buy-2-gda-get-a-pill-case-for-free","title":"Buy 2 GDA Get A 7-Day Pill Case For FREE","description":"\u003cp\u003eCore Nutritionals® Lifeline GDA has redefined what a true glucose disposal agent should be. While most GDAs on the market rely on single-pathway, underdosed formulas, Core Life Line GDA targets multiple critical pathways through clinical or near-clinical serving sizes. More importantly, it utilizes non-redundant ingredients that precisely target both glycogenic (glycogen-creating) and lipolytic (fat-mitigating) processes.\u003c\/p\u003e\n\u003cp\u003eThe effectiveness of Core Life Line GDA lies in its ability to influence key pathways of glycogen storage and lipid metabolism. This includes increasing GLUT4 translocation to enhance glucose uptake into muscle cells, improving insulin sensitivity, and modulating the body’s response to carbohydrate intake at both the digestive and cellular level.\u003c\/p\u003e\n\u003cp\u003eWhile other GDAs may attempt to target similar pathways, Core Life Line GDA does so through multiple distinct mechanisms. Rather than relying on a single ingredient approach, it maximizes glycogen storage while minimizing the likelihood of excess glucose being stored as body fat.\u003c\/p\u003e\n\u003cp\u003eWhen you consume carbohydrates, they are broken down into glucose and released into the bloodstream. From there, glucose is either directed toward muscle tissue—where it can be stored as glycogen and used for performance—or toward adipose tissue for storage as fat.\u003c\/p\u003e\n\u003cp\u003eBy enhancing glycogen storage, Core Life Line GDA helps fuel performance, recovery, and muscle fullness, while acting as a safeguard against fat storage. At the same time, it works to stabilize blood glucose levels and reduce pathways associated with fat accumulation.\u003c\/p\u003e\n\u003cp\u003eThe result is a comprehensive, multi-pathway system designed to optimize nutrient utilization, support performance, and promote a leaner physique.\u003c\/p\u003e\n\u003cp\u003eCore Life Line GDA sets a new standard for GDAs.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eScientific Write-Up: Chromium (as Chromium Picolinate) (Chromax®)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eChromium, a naturally occurring trace element in many foods, has been linked to benefits including weight management, body composition, cognitive health, glucose metabolism, appetite control, and energy support.\u003c\/p\u003e\n\u003cp\u003eChromax® Chromium Picolinate is a highly bioavailable form of chromium that has been extensively studied for its benefits listed above.\u003c\/p\u003e\n\u003cp\u003ePerhaps chromium picolinates’ most important function that leads to these benefits is in its ability to regulate insulin through carbohydrate, lipid, and protein metabolism.\u003c\/p\u003e\n\u003cp\u003eThe proposed mechanism of action is through its ability to regulate glucose utilization and increase sensitivity of insulin receptors by prolonging kinase activity through stimulating the tyrosine kinase pathway, thus leading to improved glucose absorption.\u003c\/p\u003e\n\u003cp\u003eThis further then leads to more stable blood sugar, which can reduce cravings, overall caloric intake, and reduce cravings, thus leading to improved body composition.\u003c\/p\u003e\n\u003cp\u003eChromax® Chromium Picolinate is particularly formulated to be up to 15x more absorbable than other traditional forms of chromium, leading to more efficient and consistent benefits.\u003c\/p\u003e\n\u003cp\u003eWhen the body can more efficiently break down food particles and shuttle their molecules to their targets for usage, the body has a much higher chance of performing optimally.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eGreen Coffee Extract (Coffea robusta) (bean) (50% Chlorogenic acid)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCoffee is widely recognized as not only the most consumed psychoactive compound on earth, but perhaps also the most consumed plant material in general.\u003c\/p\u003e\n\u003cp\u003eDue to the extent of coffee consumption by humans, several species of coffee beans, along with their bioactive constituents, have been research targets for a number of therapeutic pathways.\u003c\/p\u003e\n\u003cp\u003eThe most abundant polyphenol in coffee is Chlorogenic acid (CGA).\u003c\/p\u003e\n\u003cp\u003eAn abundance of data suggests that CGA has numerous physiological properties, and that its most potent physiological effects are hypoglycemic (blood sugar-lowering) and lipolytic\/anti-lipogenic in nature.\u003c\/p\u003e\n\u003cp\u003eRecent evidence demonstrates that CGA is a powerful and novel glucose modulator, in vivo, in both healthy and diseased populations.\u003c\/p\u003e\n\u003cp\u003eResearch shows that one of CGA’s potential hypoglycemic mechanisms is insulin sensitization – in other words, making existing cells more sensitive to the glucose shuttling effects of insulin.\u003c\/p\u003e\n\u003cp\u003eIn a trial on streptozotocin (STZ) (45 mg\/kgbw) nicotinamide-induced diabetic rats, a 5mg\/kgbw dose of CGA significantly mitigated the diabetic effects of STZ and caused an increase to glucose uptake.\u003c\/p\u003e\n\u003cp\u003eOf note, the 5mg\/kgbw dose of CGA used in the animal trial is significantly less than the mg\/kgbw serving size of CGA included in Core LOAD. (Assuming an average Core LOAD consumer bodyweight of 75kg.)\u003c\/p\u003e\n\u003cp\u003eAn additional trial in obese Zucker rats demonstrated that CGA is capable of improving glucose tolerance and insulin resistance.\u003c\/p\u003e\n\u003cp\u003eThe trial found that the CGA group had better glucose tolerance, higher insulin sensitivity index (ISI), and lower HOMA-IR (insulin resistance) index.\u003c\/p\u003e\n\u003cp\u003eA trial in healthy humans showed similar promise.\u003c\/p\u003e\n\u003cp\u003eHealthy, human subjects were challenged with an acute serving of CGA and then assessed for hepatic glucose output, blood glucose levels, and glucose tolerance.\u003c\/p\u003e\n\u003cp\u003eCGA induced a significant reduction in peak plasma glucose levels – an important fact, as glucose fluctuations and\/or chronically excessive blood glucose levels are associated with fat cell proliferation.\u003c\/p\u003e\n\u003cp\u003eUnlike the animal trial, however, the human trial hypothesized that CGA worked through a different, more novel mechanism: attenuating glucose absorption in the gastric uptake phase.\u003c\/p\u003e\n\u003cp\u003eIn this trial, CGA effectively CGA functioned as both an insulin sensitizing agent and a glycemic index lowering agent.\u003c\/p\u003e\n\u003cp\u003eIn addition to both the above mechanisms, CGA was shown to inhibit the activities of α-amylase and α-glucosidase – two enzymes responsible for metabolizing carbohydrates into saccharides.\u003c\/p\u003e\n\u003cp\u003eAs a result, CGA again reduced postprandial (post-meal) blood glucose concentration.\u003c\/p\u003e\n\u003cp\u003eThe potentially novel glycemic index-lowering and carbohydrate metabolism effects of CGA were confirmed in two further trials: one in which CGA intake significantly reduced fasting glucose and insulin levels in obese men, and another in which CGA lowered the glycemic impact (how quickly and to what degree plasma glucose was increased) and lowered blood glucose levels.\u003c\/p\u003e\n\u003cp\u003eCGA is an interesting compound due not only to its potent insulin-sensitizing and glycemic effects, but also its novel action on lipid metabolism.\u003c\/p\u003e\n\u003cp\u003eA 2006 trial found that CGA – in addition to caffeine and other polyphenols found in green coffee bean extract – suppressed body weight gain and the accumulation of visceral fat in mice.\u003c\/p\u003e\n\u003cp\u003eAgain, the mechanism of action was quite unique: CGA was found to inhibit and delay the absorption of fat at the gastric uptake phase and reduce lipid metabolism in the liver.\u003c\/p\u003e\n\u003cp\u003eIn a separate trial on obese rates, CGA significantly reduced body weight, visceral fat mass (adipose tissue surrounding the internal organs), and plasma insulin concentrations.\u003c\/p\u003e\n\u003cp\u003eThe authors of this trial hypothesize that, in addition to the profound effects on glucose metabolism noted above, CGA reduced body weight and fat mass due to increased fatty acid beta-oxidation activity and peroxisome proliferator-activated receptors alpha expression in the liver.\u003c\/p\u003e\n\u003cp\u003eIn sum, CGA is the perfect confluence of glycogenic, glycemic-impact lowering, insulin sensitizing, and anti-lipogenic factors.\u003c\/p\u003e\n\u003cp\u003eIts inclusion as a key ingredient in Core GDA, at well above clinical serving sizes, functions to promote healthy blood glucose levels, healthy bodyweight, and healthy insulin release.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e\u003ci\u003eGS4 Plus® Gymnema sylvestre Extract (leaves) (25% gymnemic acids)\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGymnema sylvestre is a plant endemic to the tropical and sub-tropical regions of Southeast Asa, including India and China. In these countries, G. sylvestre functions as a treatment for many pathological conditions, including diabetes and hypercholesterolemia – in fact, the Ayurvedic name for G. sylevestre is “Gurmar,” or “destroyer of sugars.” The principle bioactives in G. sylvestre, gymnemic acids, are concentrated highly in the leaves and have been isolated and observed for their glucose shuttling properties.\u003c\/p\u003e\n\u003cp\u003eIn a clinical trial in humans using a G. sylestre extract dietary supplement, 65 participants were administered G. sylvestre for 90 days. After the 90 day treatment, the participants were assessed for a number of biometrics, including prenadial (pre-eating) plasma glucose concentrations and HbA1c (haemoglobin A1c, a key marker for diabetes) levels. The researchers found that 90 days of supplementation with G. sylvestre lowered prenadial blood glucose by 11%, postpranadial glucose by 13%, and Hb1Ac by .8% (a seemingly small figure, but in fact statistically significant).\u003c\/p\u003e\n\u003cp\u003eIn another, small clinical study, fasting blood glucose levels significantly improved in a group of type II diabetes mellitus patients after receiving a 200mg extract of G. sylevestre (standardized for gymnemic acid) for 20 months.\u003c\/p\u003e\n\u003cp\u003eUnlike CGA, the mechanism(s) of action for G. sylevestre and gymnemic acid have not been precisely identified. Several trials in rats suggest that gymnemic acid’s structural similarity to glucose may have a role in its hypoglycemic effects; while still other trials suggest that, like CGA, gymemic acid may exert glucose uptake inhibitory effects at the intestinal level.\u003c\/p\u003e\n\u003cp\u003eWhatever the mechanism of action, however, the plant has demonstrated the ability to promote healthy blood glucose levels and assist in the management of a healthy body mass.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e\u003ci\u003eCeylon Cinnamon Bark Powder (Cinnamomum verum)\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCeylon cinnamon, often referred to as “true cinnamon,” is a well-studied botanical known for its powerful effects on glucose metabolism and insulin function. Unlike cassia cinnamon, Ceylon cinnamon contains significantly lower levels of coumarin, making it a safer option for consistent daily use. Its primary bioactives—cinnamaldehyde and polyphenols—have been shown to enhance insulin sensitivity by improving insulin receptor signaling.\u003c\/p\u003e\n\u003cp\u003eThis allows cells to more efficiently uptake glucose, helping to reduce circulating blood sugar levels and improve overall nutrient utilization.\u003c\/p\u003e\n\u003cp\u003eCeylon cinnamon also plays a role in slowing carbohydrate digestion by inhibiting key enzymes like α-amylase and α-glucosidase. This helps blunt post-meal blood sugar spikes, supporting more stable energy levels and reducing the likelihood of excess glucose being stored as body fat.\u003c\/p\u003e\n\u003cp\u003eClinical research supports cinnamon’s ability to lower fasting blood glucose, improve insulin sensitivity, and support long-term glycemic control.\u003c\/p\u003e\n\u003cp\u003eIn the context of Life Line GDA, Ceylon cinnamon acts as a foundational ingredient to promote efficient glucose disposal and metabolic health.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e\u003ci\u003eGlucovantage® (Dihydroberberine)\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlucovantage® is a sustained release dihydroberberine, which is a highly bioavailable derivative of berberine. Once absorbed in the intestines, dihydroberberine rapidly converts to berberine in the blood and has been shown to be up to 5x more bioavailable than standard berberine.\u003c\/p\u003e\n\u003cp\u003eThe benefits of berberine have been extensively studied for its positive effects on glucose balance, lipid metabolism, and overall blood vessel health. In fact, berberine is one of the leading compounds that is used to increase insulin sensitivity, or how well your body responds to insulin.\u003c\/p\u003e\n\u003cp\u003eGlucose uptake to tissues is influenced by berberines ability to activate the adenosine monophosphate kinase (AMPK) pathway, which plays an important role in energy balance regulation.\u003c\/p\u003e\n\u003cp\u003eResults from pre-clinical studies indicate berberine promotes healthy cholesterol metabolism by a variety of actions. It has the ability to upregulate LDL-receptors on liver cells that shuttle cholesterol out of the blood and into the necessary cells. Berberine inhibits intestinal cholesterol absorption and increases excretion as well as provides antioxidant defense.\u003c\/p\u003e\n\u003cp\u003eBy activating AMP-K, for the purposes of glucose balance, it also increases fatty acid oxidation (burning) and decreases fatty acid synthesis.\u003c\/p\u003e\n\u003cp\u003eAs a highly bioavailable form of berberine, Glucovantage® dihydroberberine may help maintain healthy blood glucose and lipid levels in the normal range while supporting vascular health.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e\u003ci\u003eBanaba Extract (Lagerstroemia speciose)(leaf)(20% corosolic acids)\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eLagerstroemia speciosa is a flowering tree of the Lagerstroemia genus that is native to large portions of south east Asia, India and the Phillipines, and its bark and leaves have a historical tradition in folk medicine for the treatment of diabetes mellitus. Banaba (L. speciosa’s common name) has been used as a folk medicine to treat diabetes in various parts of the world, primarily southeast Asia.\u003c\/p\u003e\n\u003cp\u003eThe hypoglycemic effect of aqueous (hot water) and methanol extracts have been demonstrated in many human studies. Most studies have focused on corosolic acid, the primary bioactive constituent of L. speciosa – and the compound for which Core LOAD’s banaba is standardized.\u003c\/p\u003e\n\u003cp\u003eA 12-week lifestyle intervention study, involving 56 subjects consuming a dietary supplement containing banaba, taken prior to each meal, measured body mass at the conclusion of the trial. At the end of 12 weeks, the subjects had lost an average of 6.29 kg (13.8 lb) including 3.72 kg (8.2 lb) body fat as determined by a bioelectric impedance body fat analyser.\u003c\/p\u003e\n\u003cp\u003eIn a separate, smaller study, 12 nondiabetic subjects with a baseline blood glucose level of 104 mg\/dL were given a soft gel capsule daily for 2 weeks containing 10 mg corosolic acid as a Banaba extract standardized to 18% corosolic acid. A 12% decrease in fasting glucose levels, as well as 60 min postprandial blood glucose levels, was observed after 2 weeks of administering the product. The authors also reported an average three-pound weight loss after the two weeks.\u003c\/p\u003e\n\u003cp\u003eIn an unpublished study using the same soft gel product containing 10 mg corosolic acid, 100 subjects with prediabetes or type 2 diabetes were enrolled. Half the subjects were given one soft gel containing the corosolic acid-standardized Banaba extract and the other half received a placebo for 30 days. Both fasting and 2 h postprandial blood glucose levels in the treated group decreased by 10% relative to the control (placebo) group. Also reported was an improvement in diabetic symptoms including a decrease in thirst, drowsiness, and hunger. Furthermore, no adverse effects were observed, with no changes in blood pressure, liver or kidney function, blood cell count, or hemoglobin.\u003c\/p\u003e\n\u003cp\u003eLastly, a study involving 31 subjects in a double-blind cross-over design were given a capsule containing 10 mg corosolic acid or a placebo 5 min before a 75g oral glucose tolerance test. Blood glucose levels were measured at 30 min intervals for 2h. The authors reported that corosolic acid treatment resulted in lower blood glucose levels from 60 to 120 min compared with controls, the difference being statistically significant (P \u0026lt; 0.05) at the 90 min time point. According to the authors, the corosolic acid that was used was 99% pure, thus indicating that the blood sugar lowering effect was specifically due to the corosolic acid.\u003c\/p\u003e\n\u003cp\u003eIn the context of Core GDA, the AUC (area under curve) demonstrated in this trial is important – as it demonstrates that corosolic acid exerts glucose stabilizing effects over a long time period (such as immediately before-to-after an intense workout).\u003c\/p\u003e\n\u003cp\u003eThe above clinical studies demonstrate that Banaba extract, Banaba extract standardized to corosolic acid, and corosolic acid itself, decrease fasting as well as postprandial blood glucose levels in humans. A decrease in blood glucose levels has been observed within 2 h of dosing, and the decrease is typically in the range of 10–15%, although a decrease of 30% has been reported.\u003c\/p\u003e\n\u003cp\u003eThe ability to corsolic acid to positively regulate healthy plasma glucose levels makes it a key addition to Core GDA’s glucose disposal agent lineup.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eBanaba Leaf Research Update\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eEffects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-alpha, PPAR-gamma, and LPL mRNA expressions. \u003ci\u003eLife Sci.\u003c\/i\u003e 2005 Nov 12;77( 26):3344-54. Department of Food and Nutrition, College of Human Ecology, Sookmyung Women's University, Seoul, Korea.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eEffects of malted barley extract and banaba extract on blood glucose levels in genetically diabetic mice. \u003ci\u003eJ Med Food.\u003c\/i\u003e 2004 Winter;7(4):487-90\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAntidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia speciosa leaves - banaba - in Type II diabetics. A dose-dependence study. \u003ci\u003eJ Ethnopharmacol.\u003c\/i\u003e 2003 Jul;87(1):115-7.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eJudy WV, et al. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. \u003ci\u003eJ Nutr.\u003c\/i\u003e 2001 Sep;131(9):2242-7\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAntiobesity activity of extracts from Lagerstroemia speciosa L. leaves on female KK-Ay mice. \u003ci\u003eJ Nutr Sci Vitaminol (Tokyo).\u003c\/i\u003e 1999 Dec;45(6):791-5.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHypoglycemic effect of extracts from Lagerstroemia speciosa L. banaba leaves in genetically diabetic KK-AY mice. \u003ci\u003eBiosci Biotechnol Biochem.\u003c\/i\u003e 1996 Feb;60(2):204-8.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eTannic acid in banaba herb Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. \u003ci\u003eJ Nutr.\u003c\/i\u003e 2005 Feb;135(2):165-71.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eLiu X, Kim et al. Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGuy Klein,1 et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Department of Biological Sciences, Seoul National University, San 56-1, Sillim-Dong. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eZhe Cheng et al. M. R. Olthof, P. C. H. Hollman, M. B. Katan et al., “Chlorogenic acid and caffeic acid are absorbed in humans,” \u003ci\u003eJournal of Nutrition\u003c\/i\u003e, vol. 131, no. 1, pp. 66–71, 2001. View at Google Scholar · View at Scopus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eM. N. Clifford, “Chlorogenic acids and other cinnamates—nature, occurrence and dietary burden,” \u003ci\u003eJournal of the Science of Food and Agriculture\u003c\/i\u003e, vol. 79, no. 3, pp. 362–372, 1999. View at Google Scholar · View at Scopus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eM. N. Clifford, “Chlorogenic acids and other cinnamates—nature, occurrence, dietary burden, absorption and metabolism,” \u003ci\u003eJournal of the Science of Food and Agriculture\u003c\/i\u003e, vol. 80, no. 7, pp. 1033–1043, 2000. View at Google Scholar · View at Scopus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eY. Kono, K. Kobayashi, S. Tagawa et al., “Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen,” \u003ci\u003eBiochimica et Biophysica Acta—General Subjects\u003c\/i\u003e, vol. 1335, no. 3, pp. 335–342, 1997. View at Publisher · View at Google Scholar · View at Scopus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eH. Kasai, S. Fukada, Z. Yamaizumi, S. Sugie, and H. Mori, “Action of chlorogenic acid in vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis model,” \u003ci\u003eFood and Chemical Toxicology\u003c\/i\u003e, vol. 38, no. 5, pp. 467–471, 2000. View at Publisher · View at Google Scholar · View at Scopus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eM. D. dos Santos, M. C. Almeida, N. P. Lopes, and G. E. P. de Souza, “Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid,” \u003ci\u003eBiological and Pharmaceutical Bulletin\u003c\/i\u003e, vol. 29, no. 11, pp. 2236–2240, 2006. View at Publisher · View at Google Scholar · View at Scopus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eR. Feng, Y. Lu, L. L. Bowman, Y. Qian, V. Castranova, and M. Ding, “Inhibition of activator protein-1, NF-κB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid,” \u003ci\u003eJournal of Biological Chemistry\u003c\/i\u003e, vol. 280, no. 30, pp. 27888–27895, 2005. View at Publisher · View at Google Scholar · View at Scopus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eB. K. Bassoli, P. Cassolla, G. R. Borba-Murad et al., “Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia,” \u003ci\u003eCell Biochemistry and Function\u003c\/i\u003e, vol. 26, no. 3, pp. 320–328, 2008. View at Publisher · View at Google Scholar · View at Scopus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003eF.-L. Hsu, Y.-C. Chen, and J.-T. Cheng, “Caffeic acid as active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats,” \u003ci\u003ePlanta Medica\u003c\/i\u003e, vol. 66, no. 3, pp. 228–230, 2000. View at Publisher · View at Google Scholar · View at Scopus\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eD. V. Rodriguez de Sotillo and M. Hadley, “Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa\/fa) Zucker rats,” \u003ci\u003eJournal of Nutritional Biochemistry\u003c\/i\u003e, vol. 13, no. 12, pp. 717–726, 2002. View at Publisher · View at Google Scholar · View at Scopus\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eD. V. Rodriguez de Sotillo, M. Hadley, and J. E. Sotillo, “Insulin receptor exon 11+\/- is expressed in Zucker (fa\/fa) rats, and chlorogenic acid modifies their plasma insulin and liver protein and DNA,” \u003ci\u003eJournal of Nutritional Biochemistry\u003c\/i\u003e, vol. 17, no. 1, pp. 63–71, 2006. View at Publisher · View at Google Scholar · View at Scopus\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eP. Nicasio, L. Aguilar-Santamaría, E. Aranda, S. Ortiz, and M. González, “Hypoglycemic effect and chlorogenic acid content in two Cecropia species,” \u003ci\u003ePhytotherapy Research\u003c\/i\u003e, vol. 19, no. 8, pp. 661–664, 2005. View at Publisher · View at Google Scholar · View at Scopus\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eL.-T. Zhang, C.-Q. Chang, Y. Liu, and Z.-M. Chen, “Effect of chlorogenic acid on disordered glucose and lipid metabolism in db\/db mice and its mechanism,” \u003ci\u003eActa Academiae Medicinae Sinicae\u003c\/i\u003e, vol. 33, no. 3, pp. 281–286, 2011 (Chinese). View at Publisher · View at Google Scholar · View at Scopus\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eK. W. Ong, A. Hsu, and B. K. Tan, “Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation,” \u003ci\u003eBiochemical Pharmacology\u003c\/i\u003e, vol. 85, no. 9, pp. 1341–1351, 2013. View at Publisher · View at Google Scholar\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eC. W. Wan, C. N. Wong, W. K. Pin et al., “Exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α,” \u003ci\u003ePhytotherapy Research\u003c\/i\u003e, vol. 27, no. 4, pp. 545–551, 2013. View at Publisher · View at Google Scholar\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eZ. Z. Huang and C. Q. Chang, “Advances of study on glucose and lipids metabolism of chlorogenic acid regulating,” \u003ci\u003eJournal of Hygiene Research\u003c\/i\u003e, vol. 37, no. 5, pp. 637–639, 2008 (Chinese). View at Google Scholar\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eR. Gao, Y. N. Lin, G. Liang, and Y. Gao, “Absorption and metabolism of chlorogenic acid,” \u003ci\u003eChinese Journal of Experimental Traditional Medical Formulae\u003c\/i\u003e, vol. 18, no. 10, pp. 316–319, 2012 (Chinese). View at Google Scholar\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eE. E. Agardh, S. Carlsson, A. Ahlbom et al., “Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women,” \u003ci\u003eJournal of Internal Medicine\u003c\/i\u003e, vol. 255, no. 6, pp. 645–652, 2004. View at Publisher · View at Google Scholar · View at Scopus\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eW.-Y. Lin, F. Xaiver Pi-Sunyer, C.-C. Chen et al., “Coffee consumption is inversely associated with type 2 diabetes in Chinese,” \u003ci\u003eEuropean Journal of Clinical Investigation\u003c\/i\u003e, vol. 41, no. 6, pp. 659–666, 2011. View at Publisher · View at Google Scholar · View at Scopus\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eM. A. Pereira, E. D. Parker, and A. R. Folsom, “Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women,” \u003ci\u003eArchives of Internal Medicine\u003c\/i\u003e, vol. 166, no. 12, pp. 1311–1316, 2006. View at Publisher · View at Google Scholar · View at Scopus\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eMhasker KS, Caius JF. A study of Indian medicinal plants. II. \u003ci\u003eGymnema sylvestre\u003c\/i\u003e R.Br. \u003ci\u003eIndian J Med Res Memoirs\u003c\/i\u003e 1930;16:2–75.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eShanmugasundaram KR, Panneerselvam C, Sumudram P, Shanmugasundaram ERB. Insulinotropic activity of \u003ci\u003eG. sylvestre\u003c\/i\u003e, R.Br. and Indian medicinal herb used in controlling diabetes mellitus. \u003ci\u003ePharmacol Res Commun\u003c\/i\u003e 1981;13:475–86.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eShanmugasundaram ERB, Leela Gopinath K, Radha Shanmugasundaram K, Rajendran VM. Possible regeneration of the islets of Langerhans in streptozotocin diabetic rats given \u003ci\u003eGymnema sylvestre\u003c\/i\u003e leaf extracts. \u003ci\u003eJ Ethnopharmacol\u003c\/i\u003e 1990;30:265–79.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eBishayee A, Chatterjee M. Hypolipidemic and antiatherosclerotic effects of oral \u003ci\u003eGymnema sylvestre\u003c\/i\u003e R.Br. leaf extract in albino rats fed on high fat diet. \u003ci\u003ePhytother Res\u003c\/i\u003e 1994;8:118–20.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGymnema. \u003ci\u003eLawrence Review of Natural Products\u003c\/i\u003e Aug 1993 (monograph).\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFushiki T, Kojima A, Imoto T, et al. An extract of \u003ci\u003eGymnema sylvestre\u003c\/i\u003e leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats. \u003ci\u003eJ Nutr\u003c\/i\u003e 1992;122:2367–73. 1995.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eUlbricht C, Dam C, Milkin T, Seamon E, Weissner W, Woods J. Banaba (\u003ci\u003eLagerstroemia speciosa\u003c\/i\u003e L.): an evidence-based systematic review by the natural standard research collaboration. \u003ci\u003eJournal of Herbal Pharmacotherapy\u003c\/i\u003e. 2007;7(1):99–113. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePark C, Lee JS. Banaba: the natural remedy as antidiabetic drug. \u003ci\u003eBiomedical Research\u003c\/i\u003e. 2011;22:127–131.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eKlein G, Kim J, Himmeldirk K, Cao Y, Chen X. Antidiabetes and anti-obesity activity of \u003ci\u003eLagerstroemia speciosa\u003c\/i\u003e. \u003ci\u003eEvidence-based Complementary and Alternative Medicine\u003c\/i\u003e. 2007;4(4):401–407. [PMC free article] [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eKim E, Sy-Cordero A, Graf TN, Brantley SJ, Paine MF, Oberlies NH. Isolation and identification of intestinal CYP3A inhibitors from ranberry (\u003ci\u003eVaccinium macrocarpon\u003c\/i\u003e) using human intestinal microsomes. \u003ci\u003ePlanta Medica\u003c\/i\u003e. 2011;77(3):265–270. [PMC free article] [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAguirre MC, Delporte C, Backhouse N, et al. Topical anti-inflammatory activity of 2α-hydroxy pentacyclic triterpene acids from the leaves of \u003ci\u003eUgni molinae\u003c\/i\u003e. \u003ci\u003eBioorganic and Medicinal Chemistry\u003c\/i\u003e. 2006;14(16):5673–5677. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHu C, Chen L, Xin Y, Cai Q. Determination of corosolic acid in \u003ci\u003eEriobotrya japonica\u003c\/i\u003e leaves by reversed-phase high performance liquid chromatography. \u003ci\u003eSe Pu\u003c\/i\u003e. 2006;24(5):492–494. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHou W, Li Y, Zhang Q, et al. Triterpene acids isolated from \u003ci\u003eLagerstroemia speciosa\u003c\/i\u003e leaves as α-glucosidase inhibitors. \u003ci\u003ePhytotherapy Research\u003c\/i\u003e. 2009;23(5):614–618. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eLu H, Chen J, Li WL, Zhang HQ. Studies on the triterpenes from ioquat leaf (\u003ci\u003eEriobotrya japonica\u003c\/i\u003e) \u003ci\u003eZhang Yao Cai\u003c\/i\u003e. 2008;31:1351–1354. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eLu H, Xi C, Chen J, Li W. Determination of triterpenoid acids in leaves of \u003ci\u003eEriobotrya japonica\u003c\/i\u003e collected at in different seasons. \u003ci\u003eZhongguo Zhongyao Zazhi\u003c\/i\u003e. 2009;34(18):2353–2355. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRollinger JM, Kratschmar DV, Schuster D, et al. 11β-Hydroxysteroid dehydrogenase 1 inhibiting constituents from \u003ci\u003eEriobotrya japonica\u003c\/i\u003e revealed by bioactivity-guided isolation and computational approaches. \u003ci\u003eBioorganic and Medicinal Chemistry\u003c\/i\u003e. 2010;18(4):1507–1515. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eBanno N, Akihisa T, Tokuda H, et al. Triterpene acids from the leaves of \u003ci\u003ePerilla frutescens\u003c\/i\u003e and their anti-inflammatory and antitumor-promoting effects. \u003ci\u003eBioscience, Biotechnology and Biochemistry\u003c\/i\u003e. 2004;68(1):85–90. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eThuong PT, Min BS, Jin W, et al. Anti-complementary activity of ursane-type triterpenoids from \u003ci\u003eWeigela subsessilis\u003c\/i\u003e. \u003ci\u003eBiological and Pharmaceutical Bulletin\u003c\/i\u003e. 2006;29(4):830–833. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eLee MS, Thuong PT. Stimulation of glucose uptake by triterpenoids from \u003ci\u003eWeigela subsessilis\u003c\/i\u003e. \u003ci\u003ePhytotherapy Research\u003c\/i\u003e. 2010;24(1):49–53. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eYang NY, Duan JA, Li P, Qian SH. Chemical constituents of \u003ci\u003eGlechoma longituba\u003c\/i\u003e. \u003ci\u003eYaoxue Xuebao\u003c\/i\u003e. 2006;41(5):431–434. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eShen Y, Wang QH, Lin HW, Shu W, Zhou JB, Li ZY. Study on chemical constituents of \u003ci\u003ePotentilla chinensis\u003c\/i\u003e Ser. \u003ci\u003eZhong Yao Cai\u003c\/i\u003e. 2006;29(3):237–239. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eKang SH, Shi YQ, Yang CX. Triterpenoids and steroids of root of \u003ci\u003eRubus biflorus\u003c\/i\u003e. \u003ci\u003eZhong Yao Cai\u003c\/i\u003e. 2008;31(11):1669–1671. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eLiu P, Deng R, Duan H, Yin W. Chemical constituents from roots of \u003ci\u003ePhlomis umbrosa\u003c\/i\u003e. \u003ci\u003eZhongguo Zhongyao Zazhi\u003c\/i\u003e. 2009;34(7):867–870. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eIkeda Y, Chen JT, Matsuda T. \u003ci\u003eEffectiveness and safety of banabamin tablet containing extract from banaba in patients with mild type 2 diabetes.\u003c\/i\u003e Japanese Pharmacology and Therapeutics. 1999;27(5):72–73. (Jpn).\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eIkeda Y, Noguchi M, Kishi S, et al. \u003ci\u003eBlood glucose controlling effects and safety of single and long-term administration on the extract of banaba leaves.\u003c\/i\u003e Journal of Nutrition \u0026amp; Food. 2002;5:41–53. (Jpn).\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eJudy WV, Hari SP, Stogsdill WW, Judy JS, Naguib YMA, Passwater R. \u003ci\u003eAntidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia speciosa leaves in Type II diabetics: a dose-dependence study.\u003c\/i\u003e Journal of Ethnopharmacology. 2003;87(1):115–117. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eLieberman S, Spahrs R, Stanton A, Martinez L, Grinder M. \u003ci\u003eWeight loss, body measurements, and compliance: a 12-week total lifestyle intervention pilot study.\u003c\/i\u003e Alternative and Complementary Therapies. 2005;11(6):307–313.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eTsuchibe S, Kataumi S, Mori M, Mori H. \u003ci\u003eAn inhibitory effect on the increase in the postprandial glucose by banaba extract capsule enriched corosolic acid.\u003c\/i\u003e Journal for the Integrated Study of Dietary Habits. 2006;17:255–259.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFukushima M, Matsuyama F, Ueda N, et al. \u003ci\u003eEffects of corosolic acid on post-challenge plasma glucose levels.\u003c\/i\u003e Diabetes Research and Clinical Practice. 2006;73:174–177. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eZheng JQ, Zheng CM, Lu KC. \u003ci\u003eCorosolic acid-induced acute kidney injury and lactic acidosis in a patient with impaired kidney function.\u003c\/i\u003e American Journal of Kidney Disease. 2010;56(2):419–420. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGarcia F. \u003ci\u003eOn the hypoglycemic effect of a decoction of Lagerstroemia speciosa leaves (banaba) administered orally.\u003c\/i\u003e Philippine Medical Association. 1940;20:193–201.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGarcia F. \u003ci\u003eDistribution and deterioration of insulin-like principle in Lagerstroemia speciosa (banaba).\u003c\/i\u003e Acta Medica Philippina. 1941;3:99–104.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eKakuda T, Sakane I, Takihara T, Ozaki Y, Takeuchi H, Kuroyanagi M. \u003ci\u003eHypoglycemic effect of extracts from Lagerstroemia speciosa L. Leaves in genetically diabetic KK-AY mice.\u003c\/i\u003e Bioscience, Biotechnology and Biochemistry. 1996;60(2):204–208. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eSuzuki Y, Hayashi K, Sukabe I, Kakuda T. \u003ci\u003eEffects and mode of action of banaba (Lagerstroemia speciosa L.) leaf extracts on postprandial blood glucose in rats.\u003c\/i\u003e Japan Society of Nutrition and Food Science. 2001;54:131–137.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eYamaguchi Y, Yamada K, Yoshikawa N, Nakamura K, Haginaka J, Kunitomo M. \u003ci\u003eCorosolic acid prevents oxidative stress, inflammation and hypertension in SHR\/NDmcr-cp rats, a model of metabolic syndrome.\u003c\/i\u003e Life Sciences. 2006;79(26):2474–2479. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eMatsuura T, Yoshikawa Y, Masui H, Sano M. \u003ci\u003eSuppression of glucose absorption by various health teas in rats.\u003c\/i\u003e Yakugaku Zasshi. 2004;124(4):217–223. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHong H, Won JM. \u003ci\u003eEffects of malted barley extract and banaba extract on blood glucose levels in genetically diabetic mice.\u003c\/i\u003e Journal of Medicinal Food. 2004;7(4):487–490. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eYamada K, Hogokowa M, Fujimoto S. \u003ci\u003eEffect of corosolic acid on gluconeogenesis in rat liver.\u003c\/i\u003e Diabetes Research and Clinical Practice. 2008;80:48–55. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eYamada K, Hosokawa M, Yamada C, et al. \u003ci\u003eDietary corosolic acid ameliorates obesity and hepatic steatosis in KK-Ay mice.\u003c\/i\u003e Biological and Pharmaceutical Bulletin. 2008;31(4):651–655. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eDeocaris CC, Aguinaldo RR, dela Ysla JL, Asencion AS, Mojica E ERE. \u003ci\u003eHypoglycemic activity of irradiated banaba (Lagerstroemia speciosa L.) leaves.\u003c\/i\u003e Journal of Applied Sciences Research. 2005;1:95–98.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003ePark MY, Lee KS, Sung MK. \u003ci\u003eEffects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-α, PPAR-γ, and LPL mRNA expressions.\u003c\/i\u003e Life Sciences. 2005;77(26):3344–3354. [PubMed]\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eTian, H., Guo, X., Wang, X., He, Z., Sun, R., Ge, S., \u0026amp; Zhang, Z. (2013). \u003ci\u003eChromium picolinate supplementation for overweight or obese adults.\u003c\/i\u003e The Cochrane Database of Systematic Reviews, 2013(11), CD010063. https:\/\/doi.org\/10.1002\/14651858.CD010063.pub2\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eMoon, J. M., Ratliff, K. M., Hagele, A. M., Stecker, R. A., Mumford, P. W., \u0026amp; Kerksick, C. M. (2021). \u003ci\u003eAbsorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial.\u003c\/i\u003e Nutrients, 14(1), 124. https:\/\/doi.org\/10.3390\/nu14010124\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eChang, C., Roh, Y. S., Du, M., Kuo, Y. C., Zhang, Y., Hardy, M., Gahler, R., \u0026amp; Solnier, J. (2024). \u003ci\u003eDifferences in Metabolite Profiles of Dihydroberberine and Micellar Berberine in Caco-2 Cells and Humans-A Pilot Study.\u003c\/i\u003e International Journal of Molecular Sciences, 25(11), 5625. https:\/\/doi.org\/10.3390\/ijms25115625\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRanasinghe, P., Perera, S., Gunatilake, M., Abeywardene, E., Gunapala, N., Premakumara, S., Perera, K., Lokuhetty, D., \u0026amp; Katulanda, P. (2012). \u003ci\u003eEffects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model.\u003c\/i\u003e Pharmacognosy Research, 4(2), 73–79. https:\/\/doi.org\/10.4103\/0974-8490.94719\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRanasinghe, P., Galappaththy, P., Constantine, G. R., Jayawardena, R., Weeratunga, H. D., Premakumara, S., \u0026amp; Katulanda, P. (2017). \u003ci\u003eCinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial.\u003c\/i\u003e Trials, 18(1), 446. https:\/\/doi.org\/10.1186\/s13063-017-2192-0\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRanasinghe, P., Jayawardena, R., Pigera, S., Wathurapatha, W. S., Weeratunga, H. D., Premakumara, G. A. S., Katulanda, P., Constantine, G. R., \u0026amp; Galappaththy, P. (2017). \u003ci\u003eEvaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial.\u003c\/i\u003e BMC Complementary and Alternative Medicine, 17(1), 550. https:\/\/doi.org\/10.1186\/s12906-017-2067-7\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Core Nutritionals","offers":[{"title":"Default Title","offer_id":45113104072880,"sku":null,"price":99.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/2440\/0931\/files\/Frame43_92fe0c3b-eb90-4401-98e0-e45dd551e2d8.png?v=1778844751","url":"https:\/\/www.corenutritionals.com\/products\/buy-2-gda-get-a-pill-case-for-free","provider":"Core Nutritionals","version":"1.0","type":"link"}